Person · CIK 2162499

Salvia Investment

10% owner at Bambusa Therapeutics

Source: Forms 3, 4, 5 and 144 on SEC EDGAR

Sold on Form 4$0
Noticed on Form 144$0
Bought on Form 4$6M
Companies1

Holdings now

As reported after the latest Form 3, 4 or 5 at each company.

How these figures work

Options and RSUs are from the latest filing that lists them; earlier grants may also be held. Holdings can be out of date when a person stops filing.

CompanySecurityHeldShares or unitsAs of
Bambusa Therapeutics BBTXCommon StockDirectly9,264,301Nov 2, 2026 · Filing · EDGAR

Sold and noticed by quarter

Salvia Investment: dollars sold on Form 4 and noticed on Form 144 per quarter, Q1 2025 to Q4 2026$6M$0Q1 2025: $0 noticed on Form 144Q1 2025: $0 sold on Form 4Q2 2025: $0 noticed on Form 144Q2 2025: $0 sold on Form 4Q3 2025: $0 noticed on Form 144Q3 2025: $0 sold on Form 4Q4 2025: $0 noticed on Form 144Q4 2025: $0 sold on Form 4Q1 2026: $0 noticed on Form 144Q1 2026: $0 sold on Form 4Q2 2026: $0 noticed on Form 144Q2 2026: $0 sold on Form 4Q3 2026: $0 noticed on Form 144Q3 2026: $0 sold on Form 4Q4 2026: $0 noticed on Form 144Q4 2026: $0 sold on Form 4Q4 2026: $6M boughtQ1 2025Q3 2025Q1 2026Q3 2026

Sold (Form 4) Noticed (Form 144) Bought (Form 4)

Quarterly totals as a table
QuarterSold (Form 4)Noticed (Form 144)Bought (Form 4)
Q4 2026——$6M

Every transaction, by company

Each Form 3, 4 and 5 transaction in plain words, newest first.

How these figures work

Values are shares times the price each filing states; grants, exercises and gifts usually state no price. Held after is what the filing reports was held once the transaction was done, directly or through the named holder.

Bambusa Therapeutics BBTX 10% owner · filings 2026 to 2026 · bought $6M

DateTransactionSharesPriceValueHeld afterSource
Nov 2, 2026Derivative converted+4,769,701$0.00$488,889,301 directFiling · EDGAR
Nov 2, 2026Open-market or private purchase+375,000$16.00$6M9,264,301 directFiling · EDGAR
Nov 2, 2026Derivative converted
Series Seed Plus Preferred Stock
−3,135,0660 directFiling · EDGAR
Nov 2, 2026Derivative converted
Series A-1 Preferred Stock
−1,473,7750 directFiling · EDGAR
Nov 2, 2026Derivative converted
Series A-2 Preferred Stock
−160,8600 directFiling · EDGAR
All 2 Forms 3, 4, 5 and 144
FiledFormCompanyLinks
Nov 2, 2026Form 4Bambusa Therapeutics BBTXFiling · EDGAR
Oct 29, 2026Form 3Bambusa Therapeutics BBTXFiling · EDGAR

Every figure is as filed with the SEC on Forms 3, 4, 5 and 144. Holdings are the amounts reported after each person's latest filing at each company and can be out of date. Matching a Form 144 notice to Form 4 sales is SEC Tracker's inference from owner, company, dates and share counts, not something the filings state. Not investment advice. Not affiliated with the U.S. SEC.